Dyslipidemia Clinical Trials in Seoul
8 recruitingSeoul, South Korea
Showing 1–8 of 8 trials
Recruiting
Not Applicable
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Dyslipidemia Associated With Type II Diabetes Mellitus
Sin Gon Kim2,186 enrolled2 locationsNCT07359105
Recruiting
Phase 3
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals1,500 enrolled4 locationsNCT06770543
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
HypertensionDyslipidemia
JW Pharmaceutical162 enrolled1 locationNCT06643130
Recruiting
Phase 4
Effect of Ezetimibe on Gut Microbiota
Atherosclerotic Cardiovascular Disease With Dyslipidemia
Yonsei University110 enrolled1 locationNCT06784557
Recruiting
Phase 4
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Metabolic SyndromeDyslipidemiasCoronary Artery Calcification
Samsung Medical Center6,000 enrolled1 locationNCT05845424
Recruiting
Not Applicable
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
HypertensionChronic Kidney DiseasesDyslipidemias
Yonsei University642 enrolled1 locationNCT06322056
Recruiting
Not Applicable
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
DyslipidemiasT2DM (Type 2 Diabetes Mellitus)
Korea University Anam Hospital3,958 enrolled1 locationNCT06293417